A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial, setting up approvals later this year. The ...

College students today have more access to investing tools than any generation before. Between tuition, textbooks and part-time jobs, it might seem like there’s no room to start investing but the ...